Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.42 |
| ▸ | TP53 | P04637 | 3/20 | 0.41 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 4/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 2/20 | 0.39 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | FLT3 | P36888 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24740812 | 0.85 | MAPT (0.60) | MAPTTP53SLC2A1LMNATHRB | |
| SCHEMBL29925296 | 0.85 | MAPT (0.60) | MAPTTP53SLC2A1LMNATHRB | |
| SCHEMBL24619571 | 0.73 | SLC2A1 (0.61) | MAPTTP53SLC2A1LMNATHRB | |
| Formic Acid SCHEMBL30537906 | 0.71 | SLC2A1 (0.58) | MAPTTP53SLC2A1LMNATHRB | |
| SCHEMBL24619745 | 0.68 | MAPT (0.83) | MAPTTP53SLC2A1LMNATHRB | |
| SCHEMBL30086031 | 0.68 | MAPT (0.83) | MAPTTP53SLC2A1LMNATHRB | |
| SCHEMBL29925090 | 0.68 | LMNA (0.66) | MAPTTP53LMNAALDH1A1KDM4E | |
| SCHEMBL24619368 | 0.68 | LMNA (0.66) | MAPTTP53LMNAALDH1A1KDM4E | |
| SCHEMBL29925013 | 0.68 | MAPT (0.70) | MAPTTP53SLC2A1LMNAALDH1A1 | |
| SCHEMBL24619387 | 0.68 | LMNA (0.65) | MAPTTP53LMNAALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022150316-A1 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | ANIMA BIOTECH INC. (US) | 2022-07-14 | — | — | WO | disclosed |